Shares in Bayer up 6.3% in premarket on report about possible glyphosate settlement

Shares in Bayer were up 6.3% in premarket trade at broker Lang & Schwarz on Friday, driven by a report on a possible out of court settlement of a U.S. jury trial over allegations that its weed killer Roundup causes cancer.